Kabanat 60MG Injection (1.5ml) is a potent chemotherapy medication that contains Cabazitaxel as its active ingredient, delivering 60mg of the drug per milliliter. This injection is primarily used in the treatment of metastatic castration-resistant prostate cancer, particularly in patients who have previously undergone treatment with a docetaxel-based regimen. Kabanat works by inhibiting cancer cell division, thereby slowing down the progression of the disease. The formulation is designed for intravenous administration, ensuring that the drug is delivered directly into the bloodstream for maximum efficacy. As a taxane derivative, Cabazitaxel disrupts the normal function of microtubules, which are essential for cell division, making it a critical option in the oncological therapeutic arsenal. Patients receiving Kabanat should be closely monitored for side effects and overall response to treatment, as it plays a significant role in managing advanced prostate cancer.